Logo for Axsome Therapeutics Inc

Axsome Therapeutics Investor Relations Material

Latest events

Logo for Axsome Therapeutics Inc

Q4 2024

Axsome Therapeutics
Logo for Axsome Therapeutics

Q4 2024

18 Feb, 2025
Logo for Axsome Therapeutics

FDA Announcement

31 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Axsome Therapeutics Inc

Access all reports
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system (CNS) disorders. The company's portfolio includes product candidates designed to address conditions such as depression, migraines, and other neurological and psychiatric disorders. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.